BiotechTube
Home/KAHR Medical/David Levi
DL

David Levi

COO

KAHR Medical

Therapeutic Areas

Genetic DisordersOncology

KAHR Medical Pipeline

DrugIndicationPhase
KHR‑001Duchenne Muscular DystrophyPreclinical
KHR‑002Cystic FibrosisPreclinical
KHR‑003Solid Tumor Immuno‑OncologyPreclinical

Leadership Team at KAHR Medical

DE
Dr. Eli Cohen
CEO
PY
Prof. Yael Ben‑Ari
CSO
View full KAHR Medical profile